Bharat Biotech COVID-19 vaccine approved for emergency use in children aged 12-18

FILE PHOTO: OVID-19 vaccination in New Delhi

(Reuters) - Bharat Biotech's COVID-19 vaccine Covaxin has gained approval for emergency use in children aged 12 to 18, the Indian company said on Twitter

The tweet came minutes after Indian Prime Minister Narendra Modi said in an address to the nation that 15-18 year olds would start receiving COVID-19 vaccinations from Jan. 3.

(Reporting by Sabahatjahan Contractor in Bengaluru; Editing by Rupam Jain and David Goodman)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting